HPHA — Heidelberg Pharma AG Share News
0.000.00%
Last trade - 00:00- €120.70m
- €147.30m
- €1.46m
Brief: Heidelberg Pharma Secures Financing Commitment From Main Shareholder dievini
Brief: Heidelberg Pharma Announces First Patient Dosed With Antibody Targeted Amanitin Conjugate HDP-101
Brief: Heidelberg Pharma 9-month Net Loss At EUR 18.9 Mln
Brief: Heidelberg Pharma Adjusts 2021 Guidance
Brief: Heidelberg Pharma Provides Update On Phase I/IIa Clinical Trial In US
Brief: Heidelberg Pharma To Start Phase I/IIa Clinical Trial With ATAC Candidate HDP-101
Brief: Heidelberg Pharma H1 Net Loss Widens To EUR 13.1 Million
Brief: Heidelberg Pharma Raises EUR 20 Mln From Private Placement
German stocks - Factors to watch on June 16
Brief: Heidelberg Pharma To Raise Capital In Private Placement
Brief: Heidelberg Pharma FY EPS Loss Widens To EUR 0.61
Brief: Heidelberg Pharma Promotes Andras Strassz To Chief Medical Officer
Brief: Heidelberg Pharma And Indiana University Publish Results On HER2-ATAC In Science Translational Medicine
Brief: Heidelberg Pharma Says FDA Allows Start Of Phase I/IIa Trial With ATAC Candidate HDP-101
Brief: Heidelberg Pharma Gets Shareholder Loan
Brief: Heidelberg Pharma 9-Month Net Loss Widens To EUR 12.5 Million
Brief: Heidelberg Pharma Adjusts 2020 Guidance
Brief: Heidelberg Pharma Receives Milestone Payment From Partner Magenta
Brief: Heidelberg Pharma Receives Milestone Payment From Partner Magenta